Rescuing TP53 from nonsense: novel triazoles for translational readthrough via optimized drug design

Abstract Nonsense mutations introduce premature termination codons (PTCs), leading to mRNA degradation and the production of truncated, non-functional proteins. These mutations account for approximately 10% of TP53 alterations, a key driver in over 50% human cancers. Effective therapeutic strategies...

Full description

Bibliographic Details

Main Authors:	Davide Ricci, Michele Menditto, Giulia Culletta, Marco Tutone, Carla Rizzo, Andrea Pace, Laura Lentini, Ivana Pibiri
Format:	Artigo
Language:	Inglês
Published:	Nature Portfolio 2026-04-01
Series:	Scientific Reports
Subjects:	P53 Nonsense mutations Cancer Translational readthrough Computer aided drug design Triazoles
Online Access:	https://doi.org/10.1038/s41598-026-48790-y
Tags:	Add Tag No Tags, Be the first to tag this record!